Persisting chemosensory impairments in 366 healthcare workers following COVID-19: an 11-month follow-up.


Journal

Chemical senses
ISSN: 1464-3553
Titre abrégé: Chem Senses
Pays: England
ID NLM: 8217190

Informations de publication

Date de publication:
01 01 2022
Historique:
entrez: 6 5 2022
pubmed: 7 5 2022
medline: 11 5 2022
Statut: ppublish

Résumé

Olfactory and gustatory dysfunctions (OD, GD) are prevalent symptoms following COVID-19 and persist in 6%-44% of individuals post-infection. As only few reports have described their prognosis after 6 months, our main objective was to assess the prevalence of OD and GD 11-month post-COVID-19. We also aimed to determine intraclass correlation coefficients (ICC) of chemosensory self-ratings for the follow-up of chemosensory sensitivity. We designed an observational study and distributed an online questionnaire assessing chemosensory function to healthcare workers with a RT-PCR-confirmed SARS-CoV-2 infection 5- and 11-month post-COVID-19. Specifically, we assessed olfaction, gustation, and trigeminal sensitivity (10-point visual analog scale) and function (4-point Likert scale). We further measured clinically relevant OD using the Chemosensory Perception Test, a psychophysical test designed to provide a reliable remote olfactory evaluation. We included a total of 366 participants (mean [SD] age of 44.8 (11.7) years old). They completed the last online questionnaire 10.6 months (0.7) after the onset of COVID-19 symptoms. Of all participants, 307 (83.9%) and 301 (82.2%) individuals retrospectively reported lower olfactory or gustatory sensitivity during the acute phase of COVID-19. At the time of evaluation, 184 (50.3%) and 163 (44.5%) indicated reduced chemosensory sensitivity, 32.2% reported impairment of olfactory function while 24.9% exhibited clinically relevant OD. Olfactory sensitivity had a high test-retest reliability (ICC: 0.818; 95% CI: 0.760-0.860). This study suggests that chemosensory dysfunctions persist in a third of COVID-19 patients 11 months after COVID-19. OD appears to be a common symptom of post-COVID-19 important to consider when treating patients.

Identifiants

pubmed: 35522081
pii: 6581702
doi: 10.1093/chemse/bjac010
pii:
doi:

Types de publication

Journal Article Observational Study

Langues

eng

Sous-ensembles de citation

IM

Informations de copyright

© The Author(s) 2022. Published by Oxford University Press. All rights reserved. For permissions, please e-mail: journals.permissions@oup.com.

Auteurs

Nicholas Bussiere (N)

Department of Anatomy, Université du Québec à Trois-Rivières, Trois-Rivières, QC, Canada.
Faculty of Medicine, Université de Montréal, Montréal, QC, Canada.

Jie Mei (J)

Department of Anatomy, Université du Québec à Trois-Rivières, Trois-Rivières, QC, Canada.

Cindy Levesque-Boissonneault (C)

Department of Anatomy, Université du Québec à Trois-Rivières, Trois-Rivières, QC, Canada.

Mathieu Blais (M)

Centre Hospitalier Universitaire de Québec-Université Laval, Québec City, QC, Canada.

Sara Carazo (S)

Centre Hospitalier Universitaire de Québec-Université Laval, Québec City, QC, Canada.
Institut National de Santé Publique du Québec, Québec City, QC, Canada.

Francois Gros-Louis (F)

Centre Hospitalier Universitaire de Québec-Université Laval, Québec City, QC, Canada.
Department of Surgery, Faculty of Medicine, Université Laval, Québec City, QC, Canada.

Robert Laforce (R)

Centre Hospitalier Universitaire de Québec-Université Laval, Québec City, QC, Canada.
Department of Medicine, Faculty of Medicine, Université Laval, Québec City, QC, Canada.

Gaston De Serres (G)

Centre Hospitalier Universitaire de Québec-Université Laval, Québec City, QC, Canada.
Institut National de Santé Publique du Québec, Québec City, QC, Canada.
Department of Social and Preventive Medicine, Faculty of Medicine, Université Laval, Québec City, QC, Canada.

Nicolas Dupre (N)

Centre Hospitalier Universitaire de Québec-Université Laval, Québec City, QC, Canada.
Department of Medicine, Faculty of Medicine, Université Laval, Québec City, QC, Canada.

Johannes Frasnelli (J)

Department of Anatomy, Université du Québec à Trois-Rivières, Trois-Rivières, QC, Canada.

Articles similaires

[Redispensing of expensive oral anticancer medicines: a practical application].

Lisanne N van Merendonk, Kübra Akgöl, Bastiaan Nuijen
1.00
Humans Antineoplastic Agents Administration, Oral Drug Costs Counterfeit Drugs

Smoking Cessation and Incident Cardiovascular Disease.

Jun Hwan Cho, Seung Yong Shin, Hoseob Kim et al.
1.00
Humans Male Smoking Cessation Cardiovascular Diseases Female
Humans United States Aged Cross-Sectional Studies Medicare Part C
1.00
Humans Yoga Low Back Pain Female Male

Classifications MeSH